Brand name: Not yet established
Generic name: elvitegravir/cobicistat/emtricitabine/tenofovir, or EVG/COBI/FTC/TDF
Class: Boosted integrase inhibitor and NRTI -- single-tablet regimen (STR)
Manufacturer: Gilead Sciences, www.gilead.com, (800) GILEAD-5 (445-3235)
AWP: TBD; drug not yet approved at press time.
Standard Dose: One tablet (150 mg elvitegravir/150 mg cobicistat/200 mg emtricitabine/300 mg tenofovir ) once daily has been selected in the Phase 3 studies. Take missed dose as soon as possible, unless it is closer in time to your next dose. Do not double up on your next dose. Dose cannot be adjusted for people with kidney problems.View Full Article
Visit Positively Aware's website to find out more about the publication.
Add Your Comment:
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)